ClinicalTrials.gg
Sign In

Arteriosclerosis clinical trials

The registry lists 157 studies for Arteriosclerosis across more than 10 countries. 18 are recruiting or about to start. 25 of them are mainly about Arteriosclerosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 9 narrower conditions too, such as Coronary Artery Disease: 8,014 studies, 1,484 open.

Get an email when these change. Save the Arteriosclerosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
87
Status unknown
28
Recruiting
14
Terminated
12
Withdrawn
6
Active, not recruiting
6

Phase

Phase 4
24
Phase 3
10
Phase 2
9
Phase 1
8

Where

United States
45
China
26
Germany
20
Spain
14
Denmark
13
France
13

Who runs them

Medtronic Vascular (8) · OrbusNeich (5) · North Texas Veterans Healthcare System (4) · Odense University Hospital (4) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Tufts Medical Center (2) · Capital Medical University (2) · Corindus Inc. (2)

What is being tested here

Drugs under test in Arteriosclerosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rosuvastatin103
Apixaban101
Aspirin004
Clopidogrel013
Ticagrelor002
MK-0616011
Enlicitide011
Eicosapentaenoic acid ethyl ester011
Testosterone undecanoate001
Testosterone001

Drug classes tested here Statins 1 open · NSAIDs 5 · P2Y12 inhibitors 4

Coming up

2phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 14 Arteriosclerosis studies recruiting now, 7 (50%) set no upper age limit and 3 (21%) stop at 75 or younger. 0 (0%) take children under 18. 1 (7%) are for women only and 0 (0%) for men only; 4 (29%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
100 (0%)0 (0%)
189 (64%)9 (64%)
3011 (79%)11 (79%)
4011 (79%)11 (79%)
5014 (100%)13 (93%)
6514 (100%)13 (93%)
7512 (86%)11 (79%)
8510 (71%)9 (64%)

Across all 157 studies, recruiting or not: 21% stop at 75 or younger and 6% at 65; 6% take children; 3% are for women only and 1% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Arteriosclerosis studies take

Of 29 interventional studies with no phase under Arteriosclerosis, half reached primary completion within 29 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase29 mo11–56 · 29 studies——
Observational36 mo23–59 · 26 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 157. Browse all 157 → or search them.